| Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia K Porkka, P Koskenvesa, T Lundán, J Rimpiläinen, S Mustjoki, R Smykla, ... Blood, The Journal of the American Society of Hematology 112 (4), 1005-1012, 2008 | 520 | 2008 |
| Sacred natural sites B Verschuuren, J McNeely, G Oviedo, R Wild Taylor & Francis, 2012 | 449 | 2012 |
| Sacred natural sites: guidelines for protected area managers R Wild, C McLeod IUCN, 2008 | 378 | 2008 |
| Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer M Russo, S Misale, G Wei, G Siravegna, G Crisafulli, L Lazzari, G Corti, ... Cancer discovery 6 (1), 36-44, 2016 | 297 | 2016 |
| Silvestrol and Episilvestrol, Potential Anticancer Rocaglate Derivatives from Aglaia silvestris BY Hwang, BN Su, H Chai, Q Mi, LBS Kardono, JJ Afriastini, S Riswan, ... The Journal of organic chemistry 69 (10), 3350-3358, 2004 | 267 | 2004 |
| Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer E Buck, PC Gokhale, S Koujak, E Brown, A Eyzaguirre, N Tao, ... Molecular cancer therapeutics 9 (10), 2652-2664, 2010 | 243 | 2010 |
| Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin SV Bhagwat, PC Gokhale, AP Crew, A Cooke, Y Yao, C Mantis, J Kahler, ... Molecular cancer therapeutics 10 (8), 1394-1406, 2011 | 219 | 2011 |
| Novel strategies for the discovery of plant-derived anticancer agents A Kinghorn, N Farnsworth, D Soejarto, G Cordell, S Swanson, J Pezzuto, ... Pharmaceutical Biology 41 (sup1), 53-67, 2003 | 213 | 2003 |
| Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis K Gupta, P Gupta, R Wild, S Ramakrishnan, RP Hebbel Angiogenesis 3, 147-158, 1999 | 197 | 1999 |
| Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor … RJ Griffin, BW Williams, R Wild, JM Cherrington, H Park, CW Song Cancer Research 62 (6), 1702-1706, 2002 | 190 | 2002 |
| Can protected areas contribute to poverty reduction?: opportunities and limitations LM Scherl IUCN, 2004 | 183 | 2004 |
| Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF–toxin conjugate on tumor microvessel density R Wild, S Ramakrishnan, J Sedgewick, AW Griffioen Microvascular research 59 (3), 368-376, 2000 | 167 | 2000 |
| Cytotoxic Flavone Analogues of Vitexicarpin, a Constituent of the Leaves of Vitex negundo F Díaz, D Chávez, D Lee, Q Mi, HB Chai, GT Tan, LBS Kardono, S Riswan, ... Journal of Natural Products 66 (6), 865-867, 2003 | 157 | 2003 |
| Can protected areas contribute to poverty reduction LM Scherl, A Wilson, R Wild, J Blockhus, P Franks, JA McNeely, ... Opportunities and limitations 60, 2004 | 132 | 2004 |
| Conservation of biodiversity in sacred natural sites in Asia and Africa: a review of the scientific literature N Dudley, S Bhagwat, L Higgins-Zogib, B Lassen, B Verschuuren, R Wild Sacred natural sites, 19-32, 2012 | 127 | 2012 |
| Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft FR Luo, Z Yang, H Dong, A Camuso, K McGlinchey, K Fager, C Flefleh, ... Cancer chemotherapy and pharmacology 56, 455-464, 2005 | 106 | 2005 |
| Inducible expression of TGFβ, snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model GM Argast, JS Krueger, S Thomson, I Sujka-Kwok, K Carey, S Silva, ... Clinical & experimental metastasis 28, 593-614, 2011 | 90 | 2011 |
| Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression … R Wild, K Fager, C Flefleh, D Kan, I Inigo, S Castaneda, F Luo, A Camuso, ... Molecular cancer therapeutics 5 (1), 104-113, 2006 | 83 | 2006 |
| Therapeutic Synergy of Oral Taxane BMS-275183 and Cetuximab versus Human Tumor Xenografts WC Rose, R Wild Clinical cancer research 10 (21), 7413-7417, 2004 | 71 | 2004 |
| Carboplatin selectively induces the VEGF stress response in endothelial cells: potentiation of antitumor activity by combination treatment with antibody to VEGF R Wild, RPM Dings, I Subramanian, S Ramakrishnan International journal of cancer 110 (3), 343-351, 2004 | 68 | 2004 |
